deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT03246659

Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC (GRAN-T-MTC)

Phase I Clinical Trial Using a Novel CCK-2/Gastrin Receptor-localizing Radiolabelled Peptide Probe for Personalized Diagnosis and Therapy of Patients With Progressive or Metastatic Medullary Thyroid Carcinoma

Sponsor: Erasmus Medical Center

Conditions Medullary Thyroid Carcinoma
Interventions 111In-CP04 111In-CP04 with co-administration of gelofusine/gelaspan
Updated 9 times since 2017 Last updated: Mar 19, 2020 Started: Aug 31, 2016 Primary completion: Nov 30, 2018 Completion: Nov 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03246659, this PHASE1 trial focuses on Medullary Thyroid Carcinoma and remains completed. Sponsored by Erasmus Medical Center, it has been updated 9 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Sep 2019 · 10 months · monthly snapshotRecruiting~Sep 2019 – ~Apr 2020 · 7 months · monthly snapshotUnknown Status~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  5. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE1

    Status: Unknown Status → Completed

▶ Show 4 earlier versions

  1. Sep 2019 — Apr 2020 [monthly]

    Unknown Status PHASE1

    Status: Recruiting → Unknown Status

  2. Nov 2018 — Sep 2019 [monthly]

    Recruiting PHASE1

  3. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE1

  4. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Erasmus Medical Center
  • INRASTES, NCSR Demokritos, Athens, Greece
  • Jagiellonian University
  • Medical University Innsbruck
  • NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland
  • Paola Anna Erba
  • University Hospital Freiburg
  • University Medical Centre Ljubljana
Data source: Azienda Ospedaliero, Universitaria Pisana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations